CMC(SH:603122) Zheng Quan Zhi Xing·2025-06-25 19:32Core Viewpoint - The legal opinion letter issued by Beijing Global Law Firm Shanghai Branch confirms that the 2024 Annual General Meeting of Shareholders of HeFu (China) Medical Technology Co., Ltd. was convened and conducted in accordance with relevant laws and regulations, ensuring the legality and validity of the meeting procedures and voting results [1][3][22]. Group 1: Meeting Procedures - The annual general meeting was held on June 25, 2025, with the notice published on June 5, 2025, meeting the requirement of a 20-day advance notice [3][5]. - The meeting was conducted at the specified location, and both on-site and online voting options were provided to shareholders [5][6]. Group 2: Qualifications of Participants - The second board of directors of HeFu China convened a meeting on June 4, 2025, to propose the annual general meeting, confirming the board as the convener [5][6]. - A total of 3 shareholders and their proxies attended the meeting, representing 792,224 shares, which is 0.1990% of the total voting shares [5][6]. Group 3: Proposals and Voting Procedures - No additional proposals were made beyond those listed in the meeting notice, and all proposals were voted on as stated [6][22]. - The voting process combined both on-site and online methods, with shareholders required to choose one voting method [7][22]. Group 4: Voting Results - The voting results for various proposals showed overwhelming support, with the majority receiving over 99% approval [8][9][10][11][12][13][14][15][16][17][18][19][20][21]. - Specific proposals included the annual board work report, independent director's report, and financial statements, all of which received high approval rates [8][9][10][11][12][19].